Provided by Tiger Trade Technology Pte. Ltd.

AIM ImmunoTech Inc.

0.3333
-0.0747-18.31%
Volume:8.94M
Turnover:3.06M
Market Cap:4.85M
PE:-0.05
High:0.3685
Open:0.3685
Low:0.3300
Close:0.4080
52wk High:20.33
52wk Low:0.2410
Shares:14.56M
Float Shares:12.61M
Volume Ratio:0.20
T/O Rate:70.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6881
EPS(LYR):-30.8884
ROE:-3138.91%
ROA:-86.56%
PB:2.28
PE(LYR):-0.01

Loading ...

Octopus AIM VCT 2 Secures Shareholder Backing at 2026 AGM

TIPRANKS
·
Yesterday

BRIEF-Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027

Reuters
·
Yesterday

AIM ImmunoTech Strengthens Equity Position and Financial Flexibility

TIPRANKS
·
Yesterday

AIM ImmunoTech extends Streeterville promissory note maturity to June 30, 2027

Reuters
·
Yesterday

AIM ImmunoTech Inc - Extends Promissory Note Maturity to June 30, 2027; Outstanding Balance $1.68 Mln

THOMSON REUTERS
·
Yesterday

AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities

THOMSON REUTERS
·
Yesterday

Oberon AIM VCT Chair and Investment Manager Lift Stakes in Trust

TIPRANKS
·
Yesterday

AIM Vaccine Reshapes Board with New Director Nominations After Resignation

TIPRANKS
·
May 18

AIM Vaccine Sets 2025 AGM to Approve Results, Board Changes and Capital Mandates

TIPRANKS
·
May 18

Firering shareholders back major capital expansion and fundraising on AIM

TIPRANKS
·
May 18

Restore Cuts Share Count with Mid‑May Buyback on AIM

TIPRANKS
·
May 18

Hargreave Hale AIM VCT Enters Closed Period Ahead of Half-Year Results

TIPRANKS
·
May 18

Talon Resources to Shift Listing from LSE Main Market to AIM

TIPRANKS
·
May 18

AIM ImmunoTech Q1 EPS $(0.69) Down From $(0.05) YoY, Sales $22.000K Miss $100.000K Estimate

Benzinga
·
May 16

AIM ImmunoTech Q1 net loss narrows 18.4% to $3.02 million

Reuters
·
May 16

Octopus AIM VCT 2 Issues New Shares and Updates Voting Rights

TIPRANKS
·
May 15

Hargreave Hale AIM VCT Expands Capital Base with New Share Allotment

TIPRANKS
·
May 15

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

GlobeNewswire
·
May 14

Reabold Co-CEO Increases Stake as New Shares Admit to AIM

TIPRANKS
·
May 14

Essensys Sets General Meeting to Approve AIM Delisting and Move to Private Status

TIPRANKS
·
May 14